Background Image
Table of Contents Table of Contents
Previous Page  12 / 772 Next Page
Information
Show Menu
Previous Page 12 / 772 Next Page
Page Background

10

Two of the better forecasters out there are

GMO

and

Research Affiliates. Lately,

GMO

has been a little

more on target, though both have favored emerging

markets over the United States. I wouldn’t suggest

remaking your portfolio based on either firm’s fore-

casts, but I think it helps to understand the lay of

the land and figure good landing spots for your next

investment. I’ve included a table of each firm’s

forecasts and their actual allocations in portfolios

with the widest discretion.

Let’s start with

GMO

. It does seven-year real-return

forecasts for asset classes. Real returns mean that

inflation has been subtracted. In predicting annual-

ized returns over seven years,

GMO

is careful to note

that these are not risk-adjusted returns. So, its asset-

allocation portfolios will generally have less in higher-

risk and more in lower-risk assets than the raw

return number might suggest. See the table for each

firm’s forecasts.

The thing that jumps out about

GMO

’s figures is just

how downbeat the firm is about a number of

core asset classes.

GMO

projects losses for U.S.

large caps, U.S. small caps, U.S. bonds, international

hedged bonds, and cash. Ouch. So, what looks

good? Well, U.S. high quality, foreign equity, emerging-

markets equity, and emerging-markets debt all have

positive though modest return projections. (

GMO

also

likes timber, though there aren’t many avenues for

individual investors to go on that one.)

Research Affiliates produces a graph showing

10

-

year real-return and volatility forecasts. The clear

winner in its forecasts are emerging-markets assets

of all stripes. Emerging-markets stocks are projected

to return

6

.

3%

annualized, only with the greatest

volatility of any asset class. Emerging-markets local-

currency debt is projected to have a

4

.

7%

return

with more-modest volatility, while emerging-markets

currencies are projected to have

4

.

4%

returns with

even less volatility.

Foreign equity in developed markets as measured

by the

MSCI

EAFE

Index is expected to have

a

3

.

9%

return, albeit with a fair amount of volatility.

Commodities and alternatives figure in the

2%

3%

annualized returns band, while U.S. large caps have

a miserable

1%

return and U.S. small caps a

0%

return with very high volatility. Long-term Treasuries

are projected to have a

0

.

7%

return with significant

volatility, while short-term Treasuries will have a

miserable

0

.

1%

annualized

10

-year return.

œ

Asset Forecasts See Meager Returns

The Contrarian

|

Russel Kinnel

Our Contrarian Approach

I go against the grain to find

overlooked funds that may be

ready to rally.

Two Bold Forecasts

GMO 7-Yr

Forecast %

Research

Affiliates 10-Yr

Forecast %

U.S. Large Caps

-1.70

0.70

U.S. High Quality

1.50

U.S. Small Caps

-2.90

0.00

EAFE Equity

1.90

3.90

Foreign Small

2.10

Emerging-Markets Equity

3.80

6.30

Commodities

2.70

U.S. Core Bonds

-0.30

1.00

U.S. TIPS

0.00

1.10

Long-Term Treasuries

0.70

Short-Term Treasuries

-0.30

0.10

High Yield

2.10

Emerging-Markets Bonds

2.10

4.70

Alternatives

2.40

Note: Figures are annualized. GMO’s figures subtract inflation. GMO’s forecast

is as of Nov. 30, 2014, and Research Affiliates’ is as of Sept. 30, 2014.